Are we entering an era of combined biologic use for severe asthma?
Yıl: 2022 Cilt: 70 Sayı: 4 Sayfa Aralığı: 403 - 404 Metin Dili: İngilizce DOI: 10.5578/tt.20229613 İndeks Tarihi: 16-05-2023
Are we entering an era of combined biologic use for severe asthma?
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. Kuruvilla ME, Lee FEH, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol 2019; 56(2): 219-33. https://doi. org/10.1007/s12016-018-8712-1
- 2. Ortega G, Tongchinsub P, Carr T. Combination biologic therapy for severe persistent asthma. Ann Allergy Asthma Immunol 2019; 123(3): 309-11. https://doi.org/10.1016/j. anai.2019.06.013
- 3. Lommatzsch M, Suhling H, Korn S, Bergmann KC, Schreiber J, Bahmer T, et al. Safety of combining biologics in severe asthma: Asthma-related and unrelated combinations. Allergy 2022; 77(9): 2839-43. https://doi. org/10.1111/all.15379
- 4. Khan D, Nicolaides R. Patient outcomes and safety of dual biologic therapies. J Allergy Clin Immunol 2020; 145(2): AB23. https://doi.org/10.1016/j.jaci.2019.12.798
- 5. Wechsler ME, Ruddy MK, Pavord ID, Israel E, Rabe KF, Ford LB, et al. Efficacy and safety of itepekimab in patients with moderate-to-severe asthma. N Engl J Med 2021; 385(18): 1656-68. https://doi.org/10.1056/ NEJMoa2024257
- 6. Papaioannou AI, Fouka E, Papakosta D, Papiris S, Loukides S. Switching between biologics in severe asthma patients. When the first choice is not proven to be the best. Clin Exp Allergy 2021; 51(2): 221-7. https://doi.org/10.1111/ cea.13809
| APA | arslan b, ŞEKER S, Yilmaz I (2022). Are we entering an era of combined biologic use for severe asthma?. , 403 - 404. 10.5578/tt.20229613 |
| Chicago | arslan bahar,ŞEKER SERHAT,Yilmaz Insu Are we entering an era of combined biologic use for severe asthma?. (2022): 403 - 404. 10.5578/tt.20229613 |
| MLA | arslan bahar,ŞEKER SERHAT,Yilmaz Insu Are we entering an era of combined biologic use for severe asthma?. , 2022, ss.403 - 404. 10.5578/tt.20229613 |
| AMA | arslan b,ŞEKER S,Yilmaz I Are we entering an era of combined biologic use for severe asthma?. . 2022; 403 - 404. 10.5578/tt.20229613 |
| Vancouver | arslan b,ŞEKER S,Yilmaz I Are we entering an era of combined biologic use for severe asthma?. . 2022; 403 - 404. 10.5578/tt.20229613 |
| IEEE | arslan b,ŞEKER S,Yilmaz I "Are we entering an era of combined biologic use for severe asthma?." , ss.403 - 404, 2022. 10.5578/tt.20229613 |
| ISNAD | arslan, bahar vd. "Are we entering an era of combined biologic use for severe asthma?". (2022), 403-404. https://doi.org/10.5578/tt.20229613 |
| APA | arslan b, ŞEKER S, Yilmaz I (2022). Are we entering an era of combined biologic use for severe asthma?. Tüberküloz ve Toraks, 70(4), 403 - 404. 10.5578/tt.20229613 |
| Chicago | arslan bahar,ŞEKER SERHAT,Yilmaz Insu Are we entering an era of combined biologic use for severe asthma?. Tüberküloz ve Toraks 70, no.4 (2022): 403 - 404. 10.5578/tt.20229613 |
| MLA | arslan bahar,ŞEKER SERHAT,Yilmaz Insu Are we entering an era of combined biologic use for severe asthma?. Tüberküloz ve Toraks, vol.70, no.4, 2022, ss.403 - 404. 10.5578/tt.20229613 |
| AMA | arslan b,ŞEKER S,Yilmaz I Are we entering an era of combined biologic use for severe asthma?. Tüberküloz ve Toraks. 2022; 70(4): 403 - 404. 10.5578/tt.20229613 |
| Vancouver | arslan b,ŞEKER S,Yilmaz I Are we entering an era of combined biologic use for severe asthma?. Tüberküloz ve Toraks. 2022; 70(4): 403 - 404. 10.5578/tt.20229613 |
| IEEE | arslan b,ŞEKER S,Yilmaz I "Are we entering an era of combined biologic use for severe asthma?." Tüberküloz ve Toraks, 70, ss.403 - 404, 2022. 10.5578/tt.20229613 |
| ISNAD | arslan, bahar vd. "Are we entering an era of combined biologic use for severe asthma?". Tüberküloz ve Toraks 70/4 (2022), 403-404. https://doi.org/10.5578/tt.20229613 |
